KIT and chronic myelogenous leukemia, BCR-ABL1 positive: Human CML LT-HSCs with low or absent c-KIT expression are enriched after exposure to TKIs, consistent with the observation that CML stem cells persisting in TKI-treated patients with CML lack c-KIT expression, supporting the clinical relevance of our work.